Table: Shin Nippon Biomedical -2023/24 group results

Shin Nippon Biomedical Laboratories

08/05/2024 01:00

May 8 (Reuters)- 
          Shin Nippon Biomedical Laboratories Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           26.45           25.09          29.84         12.00    
               (+5.4 pct)      (+41.4 pct)    (+12.8 pct)   (+1.0 pct)  
  Operating        4.16            5.25           2.35     loss 202 mln 
               (-20.6 pct)     (+25.0 pct)    (-43.5 pct)               
  Recurring        7.02            9.19           5.35          1.33    
               (-23.7 pct)     (+29.9 pct)    (-23.8 pct)   (-64.5 pct) 
  Net
  Net              5.53            6.06           3.92        858 mln   
               (-8.7 pct)      (-15.0 pct)    (-29.1 pct)   (-71.1 pct) 
  EPS          132.86 yen      145.56 yen      94.15 yen     20.60 yen  
  Ann Div       50.00 yen       50.00 yen      50.00 yen                
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen                
  -Q4 Div       30.00 yen       30.00 yen      30.00 yen                
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T